NCT02666495

Brief Summary

A reliably effective treatment model for anorexia nervosa is yet to emerge. Recent clinical trials of psychological therapies over 20-30 sessions, have shown modest benefits. There is therefore a need to test new treatments to find more effective treatments. Clinical trials of Schema Therapy have shown low rates of dropout, which is often a problem in the treatment of anorexia nervosa. Treatment with Schema Therapy, for significantly longer than 20-30 sessions, has been shown to be effective for other complex mental health problems.This pilot study is therefore designed to pilot the use of individual Schema Therapy for people with Anorexia Nervosa (iST-AN). This study is a case series pilot study. The study will answer the principal research question: Does individual Schema mode Therapy, adapted for eating disorders, have the potential to improve symptoms, quality of life and weight in people with moderate-severe anorexia nervosa? It will also address secondary research questions: Can people with moderate-severe anorexia nervosa be recruited to, and kept engaged in, a study of iST-AN treatment? What is the ideal length of iST-AN treatment? What is the relationship between self-criticism, body shame, or unhelpful psychological 'modes' and clinical outcome? Fifteen people with moderate-severe Anorexia Nervosa will be recruited from referrals to a specialist eating disorders outpatient service. The study will deliver 65 sessions of Schema Therapy for anorexia nervosa (iST-AN), over a 24 month period, alongside any additional medical or dietetic management required. Standard outcome measures will be collected at 6 month intervals. The research team have expertise in eating disorders research, schema therapy for severe anorexia nervosa and are all members of the local clinical service. The study will take place over a 3 year period.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 25, 2015

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 25, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

January 28, 2016

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2018

Completed
Last Updated

September 23, 2024

Status Verified

September 1, 2024

Enrollment Period

3.6 years

First QC Date

January 25, 2016

Last Update Submit

September 20, 2024

Conditions

Keywords

Schema Therapy

Outcome Measures

Primary Outcomes (1)

  • Eating Disorders Examination questionnaire (EDE-Q)

    A validated self-report measure of eating disorder symtpoms.

    6 monthly

Secondary Outcomes (4)

  • Body Mass INdex (BMI)

    6 monthly

  • WHO-QoL (bref)

    6 monthly

  • Symptom Check List - 90

    6 monthly

  • Global Assessment of Functioning (GAF)

    6 monthly

Other Outcomes (3)

  • Forms of Self-Criticism/Self-Reassuring scale (FSCRS)

    6 monthy

  • Body shame items of the Experiences of Shame Scale (ESS)

    6 monthly

  • Schema Mode Inventory (SMI)

    baseline and 24 months

Interventions

Psychological treatment using individual Schema-Mode Therapy for Anorexia Nervosa (iST-AN). A 60 session protocol will be used over an 18 month period, moving flexibly through five phases of treatment, guided by the psychological formulation: phase 1 - assessment, engagement \& stabilisation; phase 2 - developing trust \& understanding; phase 3 - developing awareness \& acceptance; phase 4 - testing change \& strengthening the healthy mode; phase 5 - consolidating change. A follow-up period of 6 months, with 5 further monthly sessions, will promote self-efficacy and further consolidate change. A total treatment package of 65 sessions will be offered, over 24 months.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of AN or other DSM-V underweight eating disorder diagnosis AND
  • yrs or over AND
  • Moderate-severe, treatment resistant, comorbid, or chronic 3.1. BMI 13-15 OR 3.2. BMI 15-17.5 and ≥ 1 previous treatment episode for eating disorder OR 3.3. BMI 15-17.5 and a personality disorder diagnosis OR 3.4. BMI 15-17.5 and duration of eating disorder of \> 10 yrs

You may not qualify if:

  • Diagnosis of psychotic disorder
  • Diagnosis of alcohol or drug dependence
  • Diagnosis of learning disability or autistic spectrum disorder
  • English language skills not adequate for therapy
  • Previous treatment with Schema Mode Therapy
  • Unable to make realistic commitment to attend weekly appointments

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Royal Edinburgh Hospital

Edinburgh, EH10 5HF, United Kingdom

Location

MeSH Terms

Conditions

Anorexia Nervosa

Condition Hierarchy (Ancestors)

Feeding and Eating DisordersMental Disorders

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 25, 2016

First Posted

January 28, 2016

Study Start

January 25, 2015

Primary Completion

August 31, 2018

Study Completion

August 31, 2018

Last Updated

September 23, 2024

Record last verified: 2024-09

Locations